维普期刊资源整合服务平台（V6.5）

72篇 您的检索式：作者名="Finegood"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	, Quan-titative estimation of beta cell sensitivity to glucose in the intact organism 显示文摘	Toffolo G Bergman RN Finegood DT	1980	Diabetes1980，29，12：	1
2	β-cell Mass dynamics in Zucker diabetic fatty rats: Rosiglitazone prevents the rise in net cell death显示文摘	Diane T Finegood M Dawn McArthur	2001	Diabetes2001，50，：	1
3	A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes显示文摘	Finegood DT Hramiak IM Dupre J		0，，：	1
4	The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome 显示文摘	Dunaif A Scott D Finegood D	1996	J Clin Endocrinol Metab1996，81，9：	1
5	The insulin-sensitizing agent troglitazone improves metabolic ovar syndrome 显示文摘	Dunaif A SeoR D Finegood D	1996	J Clin Endocrinol Metab1996，81，：	1
6	A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome显示文摘	Legro RS Finegood D Dunaif A	1998	J Clin Endocrinol Metab1998，83，：	1
7	Metabolic adaptations to chronic glucose infusion in rats显示文摘	B. G. Topp M. D. McArthur D. T. Finegood	2004	Diabetologia2004，，9：	1
8	Th e PPARγ agonist rosiglitazone (RSG)decreases net loss of pancreatic β-cell mas s in Zucker diabetic fatty rats显示文摘	McArthur M D Kojwang D	1999	Diabetes1999，48，23：	1
9	The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes显示文摘	Bergman P N Finegood D T Kahn S E	2002	European Journal of Clinical Investigation2002，32，1：	1
10	Glycogen synthase polymorphism,insulin resistance and hypertension显示文摘	Gharavi AG Phillips RA Finegood DT	1996	Blood Press1996，5，：	1
11	The evolution of beta- cell dysfunction and insulin resistance in type 2 diabetes显示文摘	Bergman RN Finegood DT Kahn SE	2002	Eur J Clin In vest2002，32，3：	1
12	Quantitative estimation of beta cell sensitivity to glucose in the intact organism: A minimal model of insulin kinet- ics in the dog显示文摘	TOFFOLO G BERGMAN R N FINEGOOD D T	1980	Diabetes1980，29，12：	1
13	A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome显示文摘	Legro RS Finegood D Dunaif A	1998	J Clin Endocrinol Metab1998，83，8：	1
14	Factors affecting glucose tolerance in hereditary hemochromatosis 显示文摘	Hramiak IM Finegood DT Adams PC	1997	Clin Invest Med1997，20，2：	1
15	Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome显示文摘	Dunaif A Finegood DT	1996	J Clin Endocrinol Metab1996，81，3：	1
16	Metabolic adaptations to chronic glucose infusion in rats显示文摘	Topp BG McArthur MD Finegood DT	2004	Diabetologia2004，47，9：	1
17	The PPAR-gamma agonist, rosiglitazone, reverses hyperinsulin emiaandpromotes growth of isletbetz-cellmass显示文摘	Finegood DT Mcarthur MD Dunixhand-Hoedl A	1998	Diabetes1998，，：	1
18	βCell Mass Dynamics in Zucker Diabetic Fatty Rats显示文摘	Diane T Finegood M Dawn Mc Arthur	2001	Diabetes2001，10，：	1
19	A Modified Protocol for Estimation of Insulin Sensitivity with the Minimal Model of Glucose Kinetics in Patients with Insulin-Dependent Diabetes * 显示文摘	Finegood DT Hramiak IM Dupre J	1990	J Clin Endocr Metab1990，70，6：	1
20	Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome显示文摘	DUNAIF A FINEGOOD D T	1996	J Clin Endocrinol Metab1996，81，3：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示